R-Loc 150mg 30 Tablets

Babies: It is not recommended to use in < 4 years old. Lactating mothers: It is likely to be safe to use in lactating mothers.
Limited human studies have shown that r-loc does not cause any harm to babies. Pregnancy: It is safe to use in pregnancy. Animal studies have shown limited or less harmful effects on developing baby. Driving: It is safe to use this tablet while driving. Alcohol: It is not safe to consume alcohol with this tablet.
Kidney: R-loc tablets should be used with caution in patients with kidney disease. Dosage adjustment is required.
Seek a doctor’s advice before using this medication. Liver: R-loc tablets should be used with caution in patients with liver disease. Dosage adjustment is required.
Seek a doctor’s advice before using this medication. .

Drowsiness Headache Weakness Constipation Diarrhoea.

R-loc is a histamine h2 antagonist medication. It is used to treat and prevent heartburn, indigestion, stomach ulcers, and gastric oesophageal disease.
R-loc reduces gastric acid volume and concentration by inhibiting the histamine h2-receptors reversibly, which are present in gastric cells..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Maintain a time gap of at least 2 hours between r-loc and other medications if you use any medications to treat acidity • Do not drink soft drinks, fruit juices like orange or lemon. These drinks can irritate the stomach and increase stomach acid production • Tell your doctor if you do not see any improvement after two weeks of treatment • Inform your doctor if you have kidney dysfunction.
Dose adjustment is necessary for this condition • Do not stop this treatment without informing your doctor.

Major • Alprazolam + R-loc: Concurrent use o these medications may result in increased concentration of alprazolam • Clozapine + R-loc: Concurrent use o these medications may result in increased concentration of clozapine • Domperidone + R-loc: Concurrent use o these medications may result in increased concentration of domperidone and risk of qt prolongation • Fentanyl + R-loc: Concurrent use o these medications may result in an increased risk of fentanyl toxicity • Octreotide + R-loc: Concurrent use o these medications may result in decreased bioavailability of octreotide • Tacrolimus + R-loc: Concurrent use o these medications may result in an increased risk of tacrolimus toxicity Moderate • Acenocoumarol + R-loc: Concurrent use o these medications may result in altered prothrombin time • Glipizide + R-loc: Concurrent use of these medications may result in an increased risk of glipizide exposure • Nilotinib + R-loc: Concurrent use of these medications may result in a reduction in nilotinib bioavailability.